SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

AND är defaultoperator och kan utelämnas

Träfflista för sökning "AMNE:(MEDICAL AND HEALTH SCIENCES Medical Biotechnology) "

Sökning: AMNE:(MEDICAL AND HEALTH SCIENCES Medical Biotechnology)

  • Resultat 21-30 av 6922
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
21.
  • Trigo, João Pedro, 1995, et al. (författare)
  • In vitro digestibility and Caco-2 cell bioavailability of sea lettuce (Ulva fenestrata) proteins extracted using pH-shift processing
  • 2021
  • Ingår i: Food Chemistry. - : Elsevier BV. - 0308-8146 .- 1873-7072. ; 356
  • Tidskriftsartikel (refereegranskat)abstract
    • Seaweed is a promising sustainable source of vegan protein as its farming does not require arable land, pesticides/insecticides, nor freshwater supply. However, to be explored as a novel protein source the content and nutritional quality of protein in seaweed need to be improved. We assessed the influence of pH-shift processing on protein degree of hydrolysis (%DH), protein/peptide size distribution, accessibility, and cell bioavailability of Ulva fenestrata proteins after in vitro gastrointestinal digestion. pH-shift processing of Ulva, which concentrated its proteins 3.5-times, significantly improved the %DH from 27.7±2.6% to 35.7±2.1% and the amino acid accessibility from 56.9±4.1% to 72.7±0.6%. Due to the higher amino acid accessibility, the amount of most amino acids transported across the cell monolayers was higher in the protein extracts. Regarding bioavailability, both Ulva and protein extracts were as bioavailable as casein. The protein/peptide molecular size distribution after digestion did not disclose a clear association with bioavailability.
  •  
22.
  • Munthe, Christian, 1962 (författare)
  • Pure Selection. The Ethics of Preimplantation Genetic Diagnosis and Choosing Children without Abortion
  • 1999
  • Bok (övrigt vetenskapligt/konstnärligt)abstract
    • Preimplantation ge¬netic diagnosis (PGD) is taken to mark the starting-point of a new phase in human reproduction, where the possibility of choosing children on genetic grounds without having to resort to ethi¬cally controversial procedures (such as abortion) will grad¬ually increase. Ethical and political issues actu¬alised by this develop¬ment are addressed. The discussion touches upon issues regarding the moral status of em¬bryos and gametes, the moral import of respecting individual auton¬omy and its implications for the requirement of informed consent in health-care, the connec¬tion between sickness, dis¬ability and the value of life, the moral status of possible future people, and the connection between choosing children and eugenic policies of the past. Practical policy issues are adressed on the basis of this, as well as an empirical case-study of the intro¬duction of PGD in Sweden. The book ends up in a set of recommendations regarding the management of re¬search on, introduction and routine use of procedures for pure se¬lection, both within health care and from the point of view of society as a whole. It is argued that research on such procedures should be allowed and supported by society. However, tight restrictions regarding the clinical introduction of new procedures in this area is highly desirable. A rough model for implementing such re¬strictions is also pre¬sented. It is further asserted that, although reasons of economy and safety should limit the access to pure se¬lection, society should not apply any explicit restrictions based on ideasregarding how different traits affect a person’s quality of life. It is stressed that, in order to to avoid a re¬sur¬rection of eugenic policies of the past, the development in this field un¬der¬lines the need for continued and strengthen public support to the sick, dis¬abled and mentally retarded.
  •  
23.
  • Klingström, Tomas, et al. (författare)
  • Legal & ethical compliance when sharing biospecimen
  • 2018
  • Ingår i: Briefings in Functional Genomics & Proteomics. - Oxford : Oxford University Press. - 2041-2649 .- 2041-2657. ; 17:1, s. 1-7
  • Forskningsöversikt (refereegranskat)abstract
    • When obtaining samples from biobanks, resolving ethical and legal concerns is a time-consuming task where researchers need to balance the needs of privacy, trust and scientific progress. The Biobanking and Biomolecular Resources Research Infrastructure-large Prospective Cohorts project has resolved numerous such issues through intense ommunication between involved researchers and experts in its mission to unite large  rospective study sets in Europe. To facilitate efficient communication, it is useful for onexperts to have an at least basic understanding of the regulatory systemformanaging biological samples. Laws regulating research oversight are based on national law and normally share core principles founded on international charters. In interview studies among donors, chief concerns are privacy, efficient sample utilization and access to information generated fromtheir samples. Despite a lack of clear evidence regarding which concern takes precedence, scientific as well as public discourse has largely focused on privacy concerns and the right of donors to control the usage of their samples. It is therefore important to  roactively deal with ethical and legal issues to avoid complications that delay or prevent samples from being accessed. To help biobank professionals avoid making unnecessary mistakes, we have developed this basic primer covering the relationship between ethics and law, the concept of informed consent and considerations for returning findings to donors.
  •  
24.
  • Andersson, Sören, 1957-, et al. (författare)
  • CHIMERIC MOMP ANTIGEN
  • 2015
  • Patent (populärvet., debatt m.m.)
  •  
25.
  • Gillman, Anna, et al. (författare)
  • Oseltamivir-Resistant Influenza A (H1N1) Virus Strain with an H274Y Mutation in Neuraminidase Persists without Drug Pressure in Infected Mallards
  • 2015
  • Ingår i: Applied and Environmental Microbiology. - : American Society for Microbiology. - 0099-2240 .- 1098-5336. ; 81:7, s. 2378-2383
  • Tidskriftsartikel (refereegranskat)abstract
    • Influenza A virus (IAV) has its natural reservoir in wild waterfowl, and emerging human IAVs often contain gene segments from avian viruses. The active drug metabolite of oseltamivir (oseltamivir carboxylate [OC]), stockpiled as Tamiflu for influenza pandemic preparedness, is not removed by conventional sewage treatment and has been detected in river water. There, it may exert evolutionary pressure on avian IAV in waterfowl, resulting in the development of resistant viral variants. A resistant avian IAV can circulate among wild birds only if resistance does not restrict viral fitness and if the resistant virus can persist without continuous drug pressure. In this in vivo mallard (Anas platyrhynchos) study, we tested whether an OC-resistant avian IAV (H1N1) strain with an H274Y mutation in the neuraminidase (NA-H274Y) could retain resistance while drug pressure was gradually removed. Successively infected mallards were exposed to decreasing levels of OC, and fecal samples were analyzed for the neuraminidase sequence and phenotypic resistance. No reversion to wild-type virus was observed during the experiment, which included 17 days of viral transmission among 10 ducks exposed to OC concentrations below resistance induction levels. We conclude that resistance in avian IAV that is induced by exposure of the natural host to OC can persist in the absence of the drug. Thus, there is a risk that human-pathogenic IAVs that evolve from IAVs circulating among wild birds may contain resistance mutations. An oseltamivir-resistant pandemic IAV would pose a substantial public health threat. Therefore, our observations underscore the need for prudent oseltamivir use, upgraded sewage treatment, and surveillance for resistant IAVs in wild birds.
  •  
26.
  • Gillman, Anna, et al. (författare)
  • Oseltamivir-Resistant Influenza A (H1N1) Virus Strain with an H274Y Mutation in Neuraminidase Persists without Drug Pressure in Infected Mallards
  • 2015
  • Ingår i: Applied and Environmental Microbiology. - : American Society for Microbiology. - 0099-2240 .- 1098-5336. ; 81:7, s. 2378-2383
  • Tidskriftsartikel (refereegranskat)abstract
    • Influenza A virus (IAV) has its natural reservoir in wild waterfowl and emerging human IAVs often contain gene segments from avian viruses. The active drug metabolite of oseltamivir (oseltamivir carboxylate (OC)), stockpiled as Tamiflu® for influenza pandemic preparedness, is not removed by conventional sewage treatment and has been detected in river water. There, it may there exert evolutionary pressure on avian IAV in waterfowl, resulting in development of resistant viral variants. A resistant avian IAV can circulate among wild birds only if resistance does not restrict viral fitness and if the resistant virus can persist without continuous drug pressure. In this in vivo Mallard (Anas platyrhynchos) study we tested if an OC-resistant avian IAV strain (A(H1N1)/NA-H274Y) could retain resistance while drug pressure was gradually removed. Successively infected Mallards were exposed to decreasing levels of OC, and fecal samples were analyzed for neuraminidase sequence and phenotypic resistance. No reversion to wild-type virus was observed during the experiment, which included 17 days of viral transmission in 10 ducks exposed to OC concentrations below resistance induction levels. We conclude that resistance in avian IAV, induced by OC exposure of the natural host, can persist in absence of the drug. Thus, there is a risk that human pathogenic IAVs that evolve from IAVs circulating among wild birds may contain resistance mutations. An oseltamivir resistant pandemic IAV would be a substantial public health threat. Therefore, our observations underscore the need for prudent oseltamivir use, upgraded sewage treatment and resistance surveillance of IAV in wild birds.
  •  
27.
  • Checinska, Aleksandra, et al. (författare)
  • Microbiomes of the dust particles collected from the International Space Station and Spacecraft Assembly Facilities
  • 2015
  • Ingår i: Microbiome. - : Springer Science and Business Media LLC. - 2049-2618. ; 3
  • Tidskriftsartikel (refereegranskat)abstract
    • Background - The International Space Station (ISS) is a unique built environment due to the effects of microgravity, space radiation, elevated carbon dioxide levels, and especially continuous human habitation. Understanding the composition of the ISS microbial community will facilitate further development of safety and maintenance practices. The primary goal of this study was to characterize the viable microbiome of the ISS-built environment. A second objective was to determine if the built environments of Earth-based cleanrooms associated with space exploration are an appropriate model of the ISS environment. Results - Samples collected from the ISS and two cleanrooms at the Jet Propulsion Laboratory (JPL, Pasadena, CA) were analyzed by traditional cultivation, adenosine triphosphate (ATP), and propidium monoazide–quantitative polymerase chain reaction (PMA-qPCR) assays to estimate viable microbial populations. The 16S rRNA gene Illumina iTag sequencing was used to elucidate microbial diversity and explore differences between ISS and cleanroom microbiomes. Statistical analyses showed that members of the phyla Actinobacteria, Firmicutes, and Proteobacteria were dominant in the samples examined but varied in abundance. Actinobacteria were predominant in the ISS samples whereas Proteobacteria, least abundant in the ISS, dominated in the cleanroom samples. The viable bacterial populations seen by PMA treatment were greatly decreased. However, the treatment did not appear to have an effect on the bacterial composition (diversity) associated with each sampling site. Conclusions - The results of this study provide strong evidence that specific human skin-associated microorganisms make a substantial contribution to the ISS microbiome, which is not the case in Earth-based cleanrooms. For example, Corynebacterium and Propionibacterium (Actinobacteria) but not Staphylococcus (Firmicutes) species are dominant on the ISS in terms of viable and total bacterial community composition. The results obtained will facilitate future studies to determine how stable the ISS environment is over time. The present results also demonstrate the value of measuring viable cell diversity and population size at any sampling site. This information can be used to identify sites that can be targeted for more stringent cleaning. Finally, the results will allow comparisons with other built sites and facilitate future improvements on the ISS that will ensure astronaut health.
  •  
28.
  • Trigo, João Pedro, 1995, et al. (författare)
  • Mild blanching prior to pH-shift processing of Saccharina latissima retains protein extraction yields and amino acid levels of extracts while minimizing iodine content
  • 2023
  • Ingår i: Food Chemistry. - : Elsevier BV. - 0308-8146 .- 1873-7072. ; 404
  • Tidskriftsartikel (refereegranskat)abstract
    • The seaweed Saccharina latissima is often blanched to lower iodine levels, however, it is not known how blanching affects protein extraction. We assessed the effect of blanching or soaking (80/45/12 °C, 2 min) on protein yield and protein extract characteristics after pH-shift processing of S. latissima. Average protein yields and extract amino acid levels ranked treatments as follows: blanching-45 °C ∼ control > soaking ∼ blanching-80 °C. Although blanching-45 °C decreased protein solubilization yield at pH 12, it increased isoelectric protein precipitation yield at pH 2 (p < 0.05). The former could be explained by a higher ratio of large peptides/proteins in the blanched biomass as shown by HP-SEC, whereas the latter by blanching-induced lowering of ionic strength, as verified by a dialysis model. Moreover, blanching-45 °C yielded a protein extract with 49 % less iodine compared with the control extract. We recommend blanching-45 °C since it is effective at removing iodine and does not compromise total protein extraction yield.
  •  
29.
  • Lundqvist, Johan, et al. (författare)
  • Innovative drinking water treatment techniques reduce the disinfection-induced oxidative stress and genotoxic activity
  • 2019
  • Ingår i: Water Research. - : Elsevier. - 0043-1354 .- 1879-2448. ; 5, s. 182-192
  • Tidskriftsartikel (refereegranskat)abstract
    • Disinfection of drinking water using chlorine can lead to the formation of genotoxic by-products whenchlorine reacts with natural organic matter (NOM). A vast number of such disinfection by-products(DBPs) have been identified, making it almost impossible to routinely monitor all DBPs with chemicalanalysis. In this study, a bioanalytical approach was used, measuring oxidative stress (Nrf2 activity),genotoxicity (micronucleus test), and aryl hydrocarbon receptor (AhR) activation to evaluate an innovativewater treatment process, including suspended ion exchange, ozonation, in-line coagulation,ceramic microfiltration, and granular activated carbon. Chlorination was performed in laboratory scaleafter each step in the treatment process in order to investigate the effect of each treatment process to theformation of DBPs. Suspended ion exchange had a high capacity to remove dissolved organic carbon(DOC) and to decrease UV absorbance and Nrf2 activity in non-chlorinated water. High-dose chlorination(10 mg Cl2 L-1) of raw water caused a drastic induction of Nrf2 activity, which was decreased by 70% inwater chlorinated after suspended ion exchange. Further reduction of Nrf2 activity following chlorinationwas achieved by ozonation and the concomitant treatment steps. The ozonation treatment resulted indecreased Nrf2 activity in spite of unchanged DOC levels. However, a strong correlation was found betweenUV absorbing compounds and Nrf2 activity, demonstrating that Nrf2 inducing DBPs were formedfrom pre-cursors of a specific NOM fraction, constituted of mainly aromatic compounds. Moreover, highdosechlorination of raw water induced genotoxicity. In similarity to the DOC levels, UV absorbance andNrf2 activity, the disinfection-induced genotoxicity was also reduced by each treatment step of theinnovative water treatment technique. AhR activity was observed in the water produced by the conventionalprocess and in the raw water, but the activity was clearly decreased by the ozonation step inthe innovative water treatment process.
  •  
30.
  • Munthe, Christian, 1962 (författare)
  • Precaution, bioethics and normative justification
  • 2015
  • Ingår i: Monash Bioethics Review. - : Springer Science and Business Media LLC. - 1321-2753 .- 1836-6716. ; 33:2, s. 219-225
  • Recension (övrigt vetenskapligt/konstnärligt)abstract
    • Daniel Steel’s new book on the precautionary principle illustrates the need to work ahead to fuse perspectives of epistemology and philosophy of science with those of ethics to accomplish progress in the debate on the proper role of precaution in a broad selection of bioethical areas. Steel advances the territory greatly with regard to conceptual clarity and epistemology, but from a bioethics standpoint he is mistaken in discounting the need for ethical underpinnings of a sound theory of the precautionary principle.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 21-30 av 6922
Typ av publikation
tidskriftsartikel (4965)
konferensbidrag (641)
doktorsavhandling (529)
forskningsöversikt (291)
annan publikation (249)
bokkapitel (153)
visa fler...
licentiatavhandling (38)
rapport (16)
patent (16)
bok (11)
samlingsverk (redaktörskap) (5)
recension (5)
konstnärligt arbete (4)
proceedings (redaktörskap) (1)
visa färre...
Typ av innehåll
refereegranskat (5576)
övrigt vetenskapligt/konstnärligt (1290)
populärvet., debatt m.m. (54)
Författare/redaktör
Thomsen, Peter, 1953 (281)
Palmquist, Anders, 1 ... (148)
Uhlén, Mathias (115)
Engqvist, Håkan (114)
Esposito, Marco, 196 ... (104)
Omar, Omar (94)
visa fler...
Persson, Cecilia (80)
Nielsen, Jens B, 196 ... (76)
Emanuelsson, Lena, 1 ... (74)
Hansson, Gunnar C., ... (69)
Nilsson, Peter (66)
Tolmachev, Vladimir (45)
Trobos, Margarita, 1 ... (44)
Lammi, Mikko, 1961- (43)
Karlsson, Niclas G., ... (41)
Lausmaa, Jukka (41)
Landegren, Ulf (40)
Pontén, Fredrik (38)
Johansson, Anna, 196 ... (38)
Suska, Felicia, 1974 (38)
Löfblom, John (37)
Schwenk, Jochen M. (36)
Engqvist, Håkan, 197 ... (33)
Munthe, Christian, 1 ... (32)
Los, Marek Jan (32)
Kamali-Moghaddam, Ma ... (31)
Lindahl, Anders, 195 ... (31)
Isaksson, Hanna (31)
Tengvall, Pentti (30)
Gatenholm, Paul, 195 ... (29)
Rising, Anna (29)
Johansson, Jan (29)
Laurell, Thomas (28)
Sundström, Birgitta (28)
Sandberg, Frida (27)
Orlova, Anna (26)
Mardinoglu, Adil, 19 ... (26)
Ståhl, Stefan (26)
Rockberg, Johan (26)
Nilsson, Bo (24)
Knutsson, Hans (24)
Wittung-Stafshede, P ... (24)
Svensson, Sara, 1981 (24)
Nilsson, Mats (23)
Tenje, Maria (23)
Li, Jin-Ping (23)
Lundeberg, Joakim (23)
Hilborn, Jöns (23)
Almqvist, Sofia, 198 ... (23)
Kingham, Paul J. (23)
visa färre...
Lärosäte
Göteborgs universitet (1637)
Uppsala universitet (1546)
Kungliga Tekniska Högskolan (941)
Karolinska Institutet (850)
Chalmers tekniska högskola (848)
Umeå universitet (830)
visa fler...
Lunds universitet (760)
Linköpings universitet (625)
Örebro universitet (280)
Stockholms universitet (264)
Sveriges Lantbruksuniversitet (216)
Malmö universitet (122)
RISE (110)
Linnéuniversitetet (109)
Karlstads universitet (70)
Högskolan i Skövde (68)
Högskolan i Borås (67)
Luleå tekniska universitet (49)
Högskolan Kristianstad (31)
Jönköping University (31)
Mittuniversitetet (29)
Högskolan i Halmstad (25)
Gymnastik- och idrottshögskolan (17)
Mälardalens universitet (13)
Södertörns högskola (12)
Högskolan Dalarna (12)
Högskolan i Gävle (11)
Blekinge Tekniska Högskola (6)
Högskolan Väst (5)
Röda Korsets Högskola (3)
Marie Cederschiöld högskola (2)
VTI - Statens väg- och transportforskningsinstitut (1)
Sophiahemmet Högskola (1)
visa färre...
Språk
Engelska (6860)
Svenska (52)
Odefinierat språk (2)
Kinesiska (2)
Tyska (1)
Ryska (1)
visa fler...
Finska (1)
Arabiska (1)
Ungerska (1)
Rumänska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (6895)
Naturvetenskap (1489)
Teknik (982)
Lantbruksvetenskap (124)
Samhällsvetenskap (86)
Humaniora (56)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy